Public annual accounts

DR. WOESTENBURG ANNEMIE financials

Name: DR. WOESTENBURG ANNEMIE financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DR. WOESTENBURG ANNEMIE, with comparable measures and links to available source documents.

Company overview

Registry number

0838686447

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for DR. WOESTENBURG ANNEMIE

2025 versus 2024

Operating line: €441,586
EBITDA: €439,526
Total assets: €2,429,910
Equity: €1,415,244

EBITDA margin +99.5% · Equity ratio +58.2%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Sept 2025	€441,586	€439,526	€2,429,910	€1,415,244	-
202430 Sept 2024	€421,955	€419,926	€2,242,610	€1,286,687	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202530 Sept 2025

€441,586

€439,526

€2,429,910

€1,415,244

202430 Sept 2024

€421,955

€419,926

€2,242,610

€1,286,687